A localizing replicon RNA vaccine harnesses the intramuscular immune microenvironment to drive adaptive responses
Preprint
- 12 November 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Intramuscular administration of self-amplifying replicon RNA (repRNA) formulated with the cationic nanocarrier LION™ represents a promising strategy for inducing durable protective immunity with minimal doses and limited systemic reactogenicity. However, the cellular and molecular mechanisms by which it elicits adaptive immune responses remain incompletely understood. Here, we demonstrate that repRNA delivery generates a microenvironment within skeletal muscle that promotes adaptive immune responses. In this local environment, repRNA-transfected muscle cells transfer antigen-encoding RNA and proteins to antigen-presenting cells to cross-prime CD8⁺ T cells, while CD4⁺ T cells and CD138⁺ cells expand in parallel with antibody production. CD4⁺ T cells are required for humoral immunity, and intramuscular CD138⁺ cell frequencies correlate with serum antibody levels. These findings reveal a coordinated mechanism by which the muscle microenvironment orchestrates adaptive immunity following localized repRNA delivery and provide mechanistic insight for the rational design of next-generation RNA vaccines and therapeutics.Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Antigen-dependent interplay of formulation, systemic innate responses, and antibody responses to multi-component replicon RNA vaccinationMolecular Therapy Nucleic Acids, 2025
- Distinct Requirements for CD4+ T Cell Help for Immune Responses Induced by mRNA and Adenovirus‐Vector SARS‐CoV‐2 VaccinesEuropean Journal of Immunology, 2024
- Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccinesMolecular Therapy Nucleic Acids, 2022
- Innate immune mechanisms of mRNA vaccinesImmunity, 2022
- Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccineEBioMedicine, 2022
- Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challengeEBioMedicine, 2022
- Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responsesImmunity, 2021
- A Special Population of Regulatory T Cells Potentiates Muscle RepairCell, 2013
- The RIG-I-like Receptor LGP2 Controls CD8+ T Cell Survival and FitnessImmunity, 2012
- Liposomes for Specific Depletion of Macrophages from Organs and Tissues2009